Why Did SoundHound AI Stock Go Up?
SoundHound AI (NASDAQ:SOUN) has moved higher in recent days, breaking…
Sell
20
HCAT Quote, Financials, Valuation and Earnings
Last price:
$2.24
Seasonality move
:
-20.94%
Day range:
$2.29 - $2.45
52-week range:
$2.02 - $5.92
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.51x
P/B ratio:
0.50x
Volume:
550.8K
Avg. volume:
587.5K
1-year change:
-57.93%
Market cap:
$166.9M
Revenue:
$306.6M
EPS (TTM):
-$1.58
Analysts' Opinion
-
Consensus RatingHealth Catalyst, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 8 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $3.88, Health Catalyst, Inc. has an estimated upside of 64.2% from its current price of $2.36.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $2.75 representing 100% downside risk from its current price of $2.36.
Fair Value
-
According to the consensus of 11 analysts, Health Catalyst, Inc. has 64.2% upside to fair value with a price target of $3.88 per share.
HCAT vs. S&P 500
-
Over the past 5 trading days, Health Catalyst, Inc. has overperformed the S&P 500 by 2.56% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Health Catalyst, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Health Catalyst, Inc. revenues have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter Health Catalyst, Inc. reported revenues of $76.3M.
Earnings Growth
-
Health Catalyst, Inc. earnings have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Health Catalyst, Inc. reported earnings per share of -$0.32.
Enterprise value:
247.5M
EV / Invested capital:
--
Price / LTM sales:
0.51x
EV / EBIT:
--
EV / Revenue:
0.78x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
-7.39x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$102.2M
Return On Assets:
-14.29%
Net Income Margin (TTM):
-34.05%
Return On Equity:
-30.29%
Return On Invested Capital:
-16.35%
Operating Margin:
-19.07%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $290M | $302.1M | $316.1M | $76.4M | $76.3M | |
| Gross Profit | $91.1M | $98M | $102.2M | $24.3M | $26.3M | |
| Operating Income | -$96M | -$63.1M | -$53M | -$12.2M | -$14.6M | |
| EBITDA | -$49.4M | -$20.1M | -$5.1M | -$2.2M | -$1.9M | |
| Diluted EPS | -$2.23 | -$1.35 | -$1.58 | -$0.24 | -$0.32 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $514M | $442.1M | $406.4M | $455.2M | $163.3M | |
| Total Assets | $845.5M | $776.2M | $712.9M | $813.1M | $587.1M | |
| Current Liabilities | $263.4M | $91.1M | $84.3M | $323.8M | $87.9M | |
| Total Liabilities | $296.3M | $336.2M | $330.5M | $458M | $255.2M | |
| Total Equity | $549.2M | $440M | $382.4M | $355M | $331.9M | |
| Total Debt | $202.1M | $244.7M | $245.9M | $361M | $168.3M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$28.9M | -$955K | -$12.7M | $6.2M | -$464K | |
| Cash From Investing | -$3.4M | $119.8M | -$77.6M | $7.6M | -$9.4M | |
| Cash From Financing | $3M | $114.5M | -$197.7M | $112.5M | -$537K | |
| Free Cash Flow | -$44.5M | -$15.5M | -$33.5M | $1.8M | -$5.6M | |
HCAT
Sector
Market Cap
$166.9M
$26M
Price % of 52-Week High
39.87%
51.81%
Dividend Yield
0%
0%
Shareholder Yield
9.15%
-1.66%
1-Year Price Total Return
-57.93%
-18.29%
Beta (5-Year)
1.690
0.485
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$2.34
200-day SMA
Sell
Level
$3.29
Bollinger Bands (100)
Sell
Level
0 - 0
Chaikin Money Flow
Sell
Level
--
20-day SMA
Sell
Level
$2.38
Relative Strength Index (RSI14)
Sell
Level
47.16
ADX Line
Neutral
Level
0
Williams %R
Neutral
Level
-46.875
50-day SMA
Sell
Level
$2.49
MACD (12, 26)
Sell
Level
-0.05
25-day Aroon Oscillator
Sell
Level
-56
On Balance Volume
Neutral
Level
--
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-1.045)
Sell
CA Score
(Annual)
Level (-0.7695)
Buy
Beneish M-Score
(Annual)
Level (-2.9952)
Sell
Momentum Score
Level (1)
Sell
Ohlson Score
Level (1.6781)
Buy
Piotroski F Score
(Annual)
Level (5)
Buy
Quality Ratio Score
Level (5)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Health Catalyst, Inc. engages in the provision of data and analytics technology and services to healthcare organizations. It operates through the Technology and Professional Services segments. The Technology segment includes its data platform, analytics applications, and support services. The Professional Services segment combines analytics, implementation, strategic advisory, outsource, and improvement services to deliver expertise to its customers. The company was founded by Steven C. Barlow and Thomas D. Burton in 2008 and is headquartered in South Jordan, UT.
Stock Forecast FAQ
In the current month, HCAT has received 3 Buy ratings 8 Hold ratings, and 0 Sell ratings. The HCAT average analyst price target in the past 3 months is $3.88.
-
Where Will Health Catalyst, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Health Catalyst, Inc. share price will rise to $3.88 per share over the next 12 months.
-
What Do Analysts Say About Health Catalyst, Inc.?
Analysts are divided on their view about Health Catalyst, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Health Catalyst, Inc. is a Sell and believe this share price will drop from its current level to $2.75.
-
What Is Health Catalyst, Inc.'s Price Target?
The price target for Health Catalyst, Inc. over the next 1-year time period is forecast to be $3.88 according to 11 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 8 analysts rate the stock a Hold.
-
Is HCAT A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Health Catalyst, Inc. is a Hold. 8 of 11 analysts rate the stock a Hold at this time.
-
How Can I Buy Shares Of HCAT?
You can purchase shares of Health Catalyst, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Health Catalyst, Inc. shares.
-
What Is The Health Catalyst, Inc. Share Price Today?
Health Catalyst, Inc. was last trading at $2.24 per share. This represents the most recent stock quote for Health Catalyst, Inc.. Yesterday, Health Catalyst, Inc. closed at $2.36 per share.
-
How To Buy Health Catalyst, Inc. Stock Online?
In order to purchase Health Catalyst, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get HCAT Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
HCAT
Sector
P/E ratio
--
23.85x
PEG ratio
-0.09x
-0.01x
P/B ratio
0.50x
1.83x
Price / LTM sales
0.51x
1.56x
Growth Metrics
HCAT
Sector
Revenue growth
-0.04%
4.18%
Earnings growth
-29.68%
9.66%
Revenue (5-year growth)
14.62%
6.28%
Earnings forecast
$0.10
-$0.18
Profitability
HCAT
Sector
Profitability FY 2024
$100.4M
$3.1M
Return on invested capital
-16.35%
-32.89%
Return on assets
-14.29%
-29.56%
Return on equity
-30.29%
-38.66%
Earnings Date
Last Earnings Date
Nov
10
Next Earnings Date
Feb
25
Estimated Next Earnings Date
Feb
9
Balance Sheet
HCAT
Sector
Total cash
$91.5M
$25.2M
Short term investments
$142.4M
$25.1M
Total assets
$858.9M
$73M
Long term debt
$168.3M
$3M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Goldman Sachs Going to Go Up?
Shares of financial giant Goldman Sachs (NYSE:GS) have soared by…
How High Will MSTR Stock Go?
After several months of pressure, shares of Bitcoin treasury Strategy…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
59
Is GOOG Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Sell
48
Is GOOGL Stock a Buy?
Market Cap: $4T
P/E Ratio: 41x
Alerts
Buy
69
INTC alert for Jan 23
Intel Corp. [INTC] is down 17.01% over the past day.
Buy
70
BNR alert for Jan 23
Burning Rock Biotech Ltd. [BNR] is down 12.81% over the past day.
Buy
80
MTRN alert for Jan 23
Materion Corp. [MTRN] is down 9.13% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
